|
Primary Care Annual Subject
Index 2002
[ Subject
| Author ]
Abortion
Early pregnancy termination. Apr:33-39
back to top
Adolescence
Bone health in young athletes with amenorrhea. Mar:9-14
The young female smoker. Apr:17-21
back to top
Alternative medicine
Essential fatty acids. Feb:31-37
Herbal products. Dec:45-49
Premenstrual syndrome, pt 1. May:37-39,54
Premenstrual syndrome, pt 2. Jul:37-39
The use of an isoflavone supplement to relieve hot flushes. Aug:47-49
Vasomotor symptom control. Nov(suppl):9-14
back to top
Autoimmune disorders
Recognizing and treating nonallergic rhinitis. Aug:29-36
back to top
Breast-feeding
Psychotropic medications, pt 2: use during lactation. Jan:32-38
back to top
Cancer
Advances in ovarian cancer. Feb(suppl):22-26
Breast cancer and sexuality. May:42-45
Breast mass management. Feb(suppl):6
Chemotherapy-induced peripheral neuropathy. Feb(suppl):27-30
Clinical trials. Feb(suppl):3-5
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:13-14,52
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
The faculty speaks: a roundtable discussion on postmenopausal health care.
Mar(suppl):32-38
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Hereditary breast cancer. Jan:15-24
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Hormone replacement and cancer. Jun(suppl):13-19
The Human Genome Project and women’s health. Jul:40-42
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Lung cancer in women. Jul:10-15
Metastatic breast cancer. Feb(suppl):18-21
The need for evidence-based medicine. Nov(suppl):3
Neoadjuvant chemotherapy. Feb(suppl):12-17
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 1. Jul:19-23
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 2. Sep:22-28
Summarizing the evidence. Nov(suppl):32-34
The TCH study. Feb(suppl):7-11
back to top
Cardiovascular
disorders
Cardiovascular disease. Mar(suppl):20-26
Cardiovascular disease. Aug:50-51
Cardiovascular disease [algorithm]. Nov(suppl):19
Cardiovascular disease in women. Jun(suppl):25-29
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:13-14,52
Critical issues in menopause. Dec(CME suppl):1-2
Estrogen and atherosclerosis. Dec(CME suppl):2-4
The Human Genome Project and women’s health. Jul:40-42
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Low-dose ERT/HRT. Jan:42-43
Summarizing the evidence. Nov(suppl):32-34
back to top
Continuing Medical
Education (CME)
Bone health in young athletes with amenorrhea. Mar:9-14
Continuous use of oral contraceptives [test]. Apr(suppl):23-24
Hirsutism. Oct:19-26
HRT and SERMs [test]. Mar(suppl):39-40
Lung cancer in women. Jul:10-15
Management of asthma in pregnancy. Jun:10-16
Managing anxiety disorders in women. Jan:25-31
Postmenopausal health care [test]. Nov(suppl):35-36
Putting WHI into perspective [test]. Dec(CME suppl):8
Raloxifene versus standard hormone replacement. May:32-36
Recognizing and treating nonallergic rhinitis. Aug:29-36
Periodontal disease and the female patient. Sep:12-16
Strategic options for cancer care [test]. Feb(suppl):31-32
Thyroid disease in pregnancy. Feb:14-20
von Willebrand disease and menorrhagia. Dec:28-32
The young female smoker. Apr:17-21
back to top
Contraception and
contraceptives
Benefits beyond contraception. Dec(suppl):12-18
Clinician-patient counseling. Dec(suppl):30-32
Combination OCs and prescribed antibiotics. Mar:40-41
Continuous OC use. Dec:50-52
Continuous oral contraceptive use. Apr(suppl):3
Contraceptive efficacy and body weight. Oct:48-50
DMPA: has it been a decade already? May:40-41,54
An evolving state. Dec(suppl):19-24
Fair access to contraception. Mar:7-8
Managing patients using the transdermal contraceptive system. Aug(suppl):26-32
Meeting today’s contraceptive needs. Aug(suppl):3
An overview of menstruation. Apr(suppl):4-7
Patterns in contraception. Dec(suppl):8-11
A planned production. Jan:40-41
Rationale for new contraceptive methods. Aug(suppl):4-13
Regulating menstruation. Apr(suppl):8-11
Substantial progress in contraception. Feb:11-12
Successful oral contraceptive use. Dec(suppl):2
Therapeutic options. Apr(suppl):12-16
Therapeutic substitution of low-dose OCs. Jan:11-12
Three new formulations. Dec(suppl):25-29
The transdermal contraceptive system. Aug(suppl):14-25
Unintended pregnancy. Dec(suppl):3-7
Words from our faculty. Apr(suppl):17-22
back to top
Dermatologic
disorders
Adding laser procedures to physicians’ practices. Jan:46
Common skin problems in older women. Jun(suppl):35-38
back to top
Diabetes
A planned production. Jan:40-41
back to top
Diet
Essential fatty acids. Feb:31-37
back to top
Editorials
The disgruntled patient. May:10
Don’t just complain…write! Sep:10-11
Fair access to contraception. Mar:7-8
FDA device approval. Apr:13-14
Keeping her healthy. Jun(suppl):11
Liability insurance. Aug:8
Medical practice: using the right model. Jul:9
The need for evidence-based medicine. Nov(suppl):3
A new era_an old problem. Jun:9
The patient from another country. Oct 10-11
Patient trust and evidence-based medicine. Nov:8-9
The poor economy will affect us, too. Dec:9
Random thoughts for the New Year. Jan:7-8
Substantial progress in contraception. Feb:11-12
back to top
Endocrinologic
disorders
Hirsutism. Oct:19-26
Thyroid disease in pregnancy. Feb:14-20
Thyroid disorders. Jun(suppl):30-34
back to top
Exercise
Bone health in young athletes with amenorrhea. Mar:9-14
Exercise and bone health. Jun:47-48
back to top
Family practice
Adding laser procedures to physicians’ practices. Jan:46
The disgruntled patient. May:10
Don’t just complain…write! Sep:10-11
Liability insurance. Aug:8
Listening. Apr:53
Medical practice: using the right model. Jul:9
A new era–an old problem. Jun:9
The patient from another country. Oct 10-11
Patient trust and evidence-based medicine. Nov:8-9
The poor economy will affect us, too. Dec:9
Random thoughts for the New Year. Jan:7-8
back to top
Gastrointestinal
disorders
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Obstetric anal sphincter lacerations, pt 1. Apr:29-32
Obstetric anal sphincter lacerations, pt 2. May:14-24
back to top
Genetics
Cracking genetic code will transform medicine. Feb:38-39
Cystic fibrosis screening in current practice. Mar:22-26
First-trimester ultrasonographic screening for aneuploidy. Oct:36-41
Genetic screening. Nov:59-60
Hereditary breast cancer. Jan:15-24
The Human Genome Project and women’s health. Jul:40-42
New opportunities in prenatal diagnosis: practical benefits from the Human
Genome Project. Sep:46-48
Recurrent first-trimester pregnancy loss. Dec:14-26
Von Willebrand disease and menorrhagia. Dec:28-32
back to top
Gynecologic disorders
Abdominal hysterectomy. Sep:31-36
Abnormal uterine bleeding. Mar:15-22
Advances in ovarian cancer. Feb(suppl):22-26
Benefits beyond contraception. Dec(suppl):12-18
Bone health in young athletes with amenorrhea. Mar:9-14
Breast cancer and sexuality. May:42-45
Breast mass management. Feb(suppl):6
Chemotherapy-induced peripheral neuropathy. Feb(suppl):27-30
Clinical trials. Feb(suppl):3-5
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:13-14,52
Continuous oral contraceptive use. Apr(suppl):3
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
The faculty speaks: a roundtable discussion on postmenopausal health care.
Mar(suppl):32-38
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Heat therapy. May:25-31
Hereditary breast cancer. Jan:15-24
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Hormone replacement and cancer. Jun(suppl):13-19
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Keeping her healthy. Jun(suppl):11
Metastatic breast cancer. Feb(suppl):18-21
The need for evidence-based medicine. Nov(suppl):3
Neoadjuvant chemotherapy. Feb(suppl):12-17
New-onset clitoromegaly associated with Alport syndrome. Nov:52-54
An overview of menstruation. Apr(suppl):4-7
Persistent sexual arousal syndrome in women. Apr:40-43
Premenstrual syndrome, pt 1. May:37-39,54
Premenstrual syndrome, pt 2. Jul:37-39
Regulating menstruation. Apr(suppl):8-11
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 1. Jul:19-23
The scientific basis for the accurate detection of early-stage epithelial ovarian
carcinoma, pt 2. Sep:22-28
SERMs in preventive health care. Nov(suppl):15-16,20-24
Summarizing the evidence. Nov(suppl):32-34
The TCH study. Feb(suppl):7-11
Therapeutic options. Apr(suppl):12-16
Three case studies in advanced disease. Nov(suppl):25-28
Unusual presentation of sarcoidosis. Jul:44-46
Uterine leiomyomas and infertility. Dec:38-42
Vasomotor symptom control. Nov(suppl):9-14
Von Willebrand disease and menorrhagia. Dec:28-32
Vulvar vestibulitis and sexual pain. Apr:44-46
Words from our faculty. Apr(suppl):17-22
back to top
Headache
Headaches in the perimenopause. Apr:47-48
back to top
Hematologic disorders
Factor V Leiden mutation, venous thromboembolism, and consideration of hormone
therapy. Nov:31-32
Von Willebrand disease and menorrhagia. Dec:28-32
back to top
Hormones and
hormone therapy
Cardiovascular disease. Mar(suppl):20-26
Cardiovascular disease [algorithm]. Nov(suppl):19
Cardiovascular disease in woman. Jun(suppl):25-29
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:13-14,52
Common skin problems in older women. Jun(suppl):35-38
Continuous oral contraceptive use. Apr(suppl):3
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
Estrogen and atherosclerosis. Dec(CME suppl):2-4
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Factor V Leiden mutation, venous thromboembolism, and consideration of hormone
therapy. Nov:31-32
The faculty speaks: a roundtable discussion on postmenopausal health care.
Mar(suppl):32-38
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Hormone replacement and cancer. Jun(suppl):13-19
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Low-dose ERT/HRT. Jan:42-43
The need for evidence-based medicine. Nov(suppl):3
Osteoporosis. Mar(suppl):5-12
Osteoporosis [algorithm]. Nov(suppl):18
An overview of menstruation. Apr(suppl):4-7
Raloxifene versus standard hormone replacement. May:32-36
Regulating menstruation. Apr(suppl):8-11
The role of HRT and SERMs. Mar(suppl):3-4
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
SERMs in preventive health care. Nov(suppl):15-16,20-24
Summarizing the evidence. Nov(suppl):32-34
Therapeutic options. Apr(suppl):12-16
Three case studies in advanced disease. Nov(suppl):25-28
Thyroid disorders. Jun(suppl):30-34
Vasomotor symptom control. Nov(suppl):9-14
Words from our faculty. Apr(suppl):17-22
back to top
Infections
Combination OCs and prescribed antibiotics. Mar:40-41
back to top
Infertility
Recurrent first-trimester pregnancy loss. Dec:14-26
Uterine leiomyomas and infertility. Dec:38-42
back to top
Laparoscopy
FDA device approval. Apr:13-14
back to top
Laser therapy
The cutting edge: laser hair removal. Mar:42
Laser vein removal. Jun:46
back to top
Menopause
Cardiovascular disease. Mar(suppl):20-26
Cardiovascular disease. Aug:50-51
Cardiovascular disease [algorithm]. Nov(suppl):19
Cardiovascular disease in woman. Jun(suppl):25-29
Cognitive function and menopause. Feb:41-42
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:13-14,52
Common skin problems in older women. Jun(suppl):35-38
Critical issues in menopause. Dec(CME suppl):1-2
Current and future directions in breast cancer care. Mar(suppl):13-19
Estrogen and atherosclerosis. Dec(CME suppl):2-4
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Exercise and bone health. Jun:47-48
Factor V Leiden mutation, venous thromboembolism, and consideration of hormone
therapy. Nov:31-32
The faculty speaks: a roundtable discussion on postmenopausal health care.
Mar(suppl):32-38
Gynecologic considerations in postmenopausal health. Mar(suppl):27-31
Headaches in the perimenopause. Apr:47-48
Hormone replacement and breast cancer. Dec(CME suppl):6-7
Hormone replacement and cancer. Jun(suppl):13-19
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Keeping her healthy. Jun(suppl):11
Low-dose ERT/HRT. Jan:42-43
The need for evidence-based medicine. Nov(suppl):3
Osteoporosis. Mar(suppl):5-12
Osteoporosis [algorithm]. Nov(suppl):18
Queen of rings. Oct:42
Raloxifene versus standard hormone replacement. May:32-36
The role of HRT and SERMs. Mar(suppl):3-4
Routine screening for cervical, breast, and colorectal cancers. Jun(suppl):20-24
SERMs in preventive health care. Nov(suppl):15-16,20-24
Sexual dialogue. Jan:44-45
Summarizing the evidence. Nov(suppl):32-34
Three case studies in advanced disease. Nov(suppl):25-28
Thyroid disorders. Jun(suppl):30-34
The use of an isoflavone supplement to relieve hot flushes. Aug:47-49
Vasomotor symptom control. Nov(suppl):9-14
back to top
Musculoskeletal
disorders
Effective use of nonsteroidal anti-inflammatory drugs. Nov:22-30
Heat therapy. May:25-31
back to top
Neurologic disorders
Diagnosis, evaluation, and management of epilepsy in women. Aug:16-26
Epilepsy in the female patient. Mar:32-39
back to top
Obesity
Contraceptive efficacy and body weight. Oct:48-50
Obstetrics and gynecology
Random thoughts for the New Year. Jan:7-8
back to top
Osteoporosis
Bone health in young athletes with amenorrhea. Mar:9-14
Combination hormone replacement therapy and the Women’s Health Initiative.
Aug:13-14,52
Critical issues in menopause. Dec(CME suppl):1-2
Estrogen, fracture, and colon cancer. Dec(CME suppl):4-6
Exercise and bone health. Jun:47-48
Implications of the Women’s Health Initiative. Nov(suppl):4-8
Low-dose ERT/HRT. Jan:42-43
The need for evidence-based medicine. Nov(suppl):3
Osteoporosis. Mar(suppl):5-12
Osteoporosis [algorithm]. Nov(suppl):18
Raloxifene versus standard hormone replacement. May:32-36
SERMs in preventive health care. Nov(suppl):15-16,20-24
Summarizing the evidence. Nov(suppl):32-34
Three case studies in advanced disease. Nov(suppl):25-28
back to top
Pain
Effective use of nonsteroidal anti-inflammatory drugs. Nov:22-30
Heat therapy. May:25-31
back to top
Patient education
All about antibiotics. S32:9-11
The best care you can give. S33:22-24
A cancer treatment guide. S33:12-16
Caregivers need care, too. S37:9-10
Combination hormone replacement therapy and the Women’s Health Initiative.
S36:7-8
Could you have diabetes and not know it? S37:3-5
On the cutting edge of breast cancer research. S33:17-19
Defend yourself against cancer. S33:2-7
Do you have a sexually transmitted disease? S32:15-16
Eating with irritable bowel syndrome. S37:15-17
Educating patients about generic medications. Sep:37-46
The feminine face of epilepsy. S32:5-8
Getting a grip on tonsillitis. S35:5-6
How we manage pain. S32:1-4
I stopped smoking, and you can, too! S34:6-7
Increase your iron intake. S32:17
Is alternative medicine right for you? S33:20-21
A kava kava caveat. S35:16-17
Making scents of our sexuality. S36:15-16
Melanoma. S34:12-13
Menopause and cancer awareness. S34:8-10
Menopause and urinary problems. S35:11-12
Milestones in breast cancer care. S33:8-11
Morning-after options for contraceptive slips. S35:13-14
New insights in fibromyalgia. S36:12-14
Preparing for natural menopause. S32:13-14
Re-examining sexual desire. S37:13-14
Save calories on fast food. S36:17
Stamp out food-borne illness. S36:9-11
Thyroid disease & genetics. S35:1-4
Turning setbacks into comebacks. S36:3-6
Understanding acne. S37:6-8
Understanding period-free contraception. S35:7-10
Understanding recent postmenopausal health care. Nov(suppl):17
Up and at ‘em! S34:11
What every woman should know about osteoporosis. S37:11-12
Your heart is in your hands. S34:1-5
Your orgasm. S34:16-17
Zap away unwanted hair. S34:15
back to top
Pharmacotherapy
Advances in ovarian cancer. Feb(suppl):22-26
Breast mass management. Feb(suppl):6
Chemotherapy-induced peripheral neuropathy. Feb(suppl):27-30
Clinical trials. Feb(suppl):3-5
Combination OCs and prescribed antibiotics. Mar:40-41
Contemporary management of human immunodeficiency virus during pregnancy. Jun
32-42
Diagnosis, evaluation, and management of epilepsy in women. Aug:16-26
Early pregnancy termination. Apr:33-39
Educating patients about generic medications. Sep:37-46
Effective use of nonsteroidal anti-inflammatory drugs. Nov:22-30
Epilepsy in the female patient. Mar:32-39
Herbal products. Dec:45-49
Hereditary breast cancer. Jan:15-24
Hirsutism. Oct:19-26
Managing anxiety disorders in women. Jan:25-31
Metastatic breast cancer. Feb(suppl):18-21
Neoadjuvant chemotherapy. Feb(suppl):12-17
Psychotropic medications, pt 2: use during lactation. Jan:32-38
Recognizing and treating nonallergic rhinitis. Aug:29-36
The TCH study. Feb(suppl):7-11
Therapeutic substitution of low-dose OCs. Jan:11-12
Use of misoprostol in practice. Jul:24-36
back to top
Pregnancy
Bereavement in multiple birth, pt 2. Feb:23-28
Broad-based conversion to elective cesarean delivery is not justified. Jun:23,29-31
Contemporary management of human immunodeficiency virus during pregnancy. Jun
32-42
Diagnosis, evaluation, and management of epilepsy in women. Aug:16-26
Early pregnancy termination. Apr:33-39
Fetal demise from food poisoning. Jul:43
First-trimester ultrasonographic screening for aneuploidy. Oct:36-41
Large condylomata acuminata in pregnancy. May:46-48
Management of asthma in pregnancy. Jun:10-16
New opportunities in prenatal diagnosis: practical benefits from the Human
Genome Project. Sep:46-48
Obstetric anal sphincter lacerations, pt 1. Apr:29-32
Obstetric anal sphincter lacerations, pt 2. May:14-24
Periodontal disease and the female patient. Sep:12-16
A planned production. Jan:40-41
Prophylactic benefits of elective cesarean delivery. Jun:22,24-28,31
Recurrent first-trimester pregnancy loss. Dec:14-26
Therapeutic substitution of low-dose OCs. Jan:11-12
Thyroid disease in pregnancy. Feb:14-20
Tilting at windmills: selected term vaginal breech delivery should not be abandoned.
Nov:43,46-51
Unintended pregnancy. Dec(suppl):3-7
Use of misoprostol in practice. Jul:24-36
Vaginal breech delivery in term singletons can no longer by justified. Nov:42,44-45
back to top
Prenatal screening
Contemporary management of human immunodeficiency virus during pregnancy. Jun
32-42
First-trimester ultrasonographic screening for aneuploidy. Oct:36-41
Genetic screening. Nov:59-60
Large condylomata acuminata in pregnancy. May:46-48
Management of asthma in pregnancy. Jun:10-16
New opportunities in prenatal diagnosis: practical benefits from the Human
Genome Project. Sep:46-48
Periodontal disease and the female patient. Sep:12-16
Recurrent first-trimester pregnancy loss. Dec:14-26
Thyroid disease in pregnancy. Feb:14-20
back to top
Preventive medicine
Cardiovascular disease [algorithm]. Nov(suppl):19
Periodontal disease and the female patient. Sep:12-16
A planned production. Jan:40-41
SERMs in preventive health care. Nov(suppl):15-16,20-24
The young female smoker. Apr:17-21
back to top
Psychiatric disorders
Bereavement in multiple birth, pt 2. Feb:23-28
Cognitive function and menopause. Feb:41-42
Managing anxiety disorders in women. Jan:25-31
Psychotropic medications, pt 2: use during lactation. Jan:32-38
back to top
Pulmonary disorders
Cystic fibrosis screening in current practice. Mar:22-26
Lung cancer in women. Jul:10-15
Management of asthma in pregnancy. Jun:10-16
The young female smoker. Apr:17-21
back to top
Quiz
Be heart healthy. S32:12
Get the skinny on dining out! S35:15
Nutrition fact…or fiction? S34:14
What you should know about…
Breast self-examination. Oct:55-56
Cesarean section. May:51-52
"Designer" estrogens. Jun:51-52
Diabetes. Mar:47-48
Epilepsy. Feb:45-46
Hormone replacement therapy. Apr:49-50
Hysterectomy. Sep:51-52
Irritable bowel syndrome. Jul:51-52
Medication use while breastfeeding. Jan:47-48
Periodontal disease. Dec:55-56
Sleep and aging. Jun(suppl):39-40
Stress incontinence. Nov:55-56
Your runny nose. Aug:55-56
back to top
Sexuality
Breast cancer and sexuality. May:42-45
Enhancing female orgasm. Mar:43-44
Female sexual dysfunction. Mar:25-30
Hypoactive sexual desire. Jun:44-45
Persistent sexual arousal syndrome in women. Apr:40-43
Re-examining sexual desire. Sep:51-52
Sexual dialogue. Jan:44-45
Vulvar vestibulitis and sexual pain. Apr:44-46
Women’s sexual pleasure and satisfaction. Aug:39-44
back to top
Sexually transmitted
diseases (STDs)
Contemporary management of human immunodeficiency virus during pregnancy. Jun
32-42
Large condylomata acuminata in pregnancy. May:46-48
back to top
Substance abuse
(alcohol, cigarettes, drugs)
Lung cancer in women. Jul:10-15
The young female smoker. Apr:17-21
back to top
Surgery
Abdominal hysterectomy. Sep:31-36
Adding laser procedures to physicians’ practices. Jan:46
Broad-based conversion to elective cesarean delivery is not justified. Jun:23,29-31
FDA device approval. Apr:13-14
Hereditary breast cancer. Jan:15-24
Lung cancer in women. Jul:10-15
Obstetric anal sphincter lacerations, pt 1. Apr:29-32
Obstetric anal sphincter lacerations, pt 2. May:14-24
Prophylactic benefits of elective cesarean delivery. Jun:22,24-28,31
Surgery for genuine stress urinary incontinence, pt 2. Nov:10-16
Surgical treatment of genuine stress urinary incontinence, pt 1. Oct:12-16
Tilting at windmills: selected term vaginal breech delivery should not be abandoned.
Nov:43,46-51
Vaginal breech delivery in term singletons can no longer by justified. Nov:
42,44-45
back to top
Ultrasonography
Abnormal uterine bleeding. Mar:15-22
back to top
Urologic disorders
New-onset clitoromegaly associated with Alport syndrome. Nov:52-54
Surgery for genuine stress urinary incontinence, pt 2. Nov:10-16
Surgical treatment of genuine stress urinary incontinence, pt 1. Oct:12-16
Unusual presentation of sarcoidosis. Jul:44-46
back to top
Vitamins and
supplements
Essential fatty acids. Feb:31-37
back to top
|
